ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 852 filers reported holding ISHARES TR in Q2 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $400,989 | -3.8% | 3,279 | -0.1% | 0.14% | 0.0% |
Q2 2023 | $416,683 | -1.7% | 3,282 | 0.0% | 0.14% | -5.9% |
Q1 2023 | $423,903 | -5.1% | 3,282 | -3.5% | 0.15% | -7.3% |
Q4 2022 | $446,649 | +12.2% | 3,402 | 0.0% | 0.16% | +0.6% |
Q3 2022 | $398,000 | -4.3% | 3,402 | -3.8% | 0.16% | +0.6% |
Q2 2022 | $416,000 | +20.9% | 3,537 | +33.8% | 0.16% | +40.9% |
Q1 2022 | $344,000 | -47.2% | 2,643 | -38.0% | 0.12% | -43.6% |
Q4 2021 | $651,000 | +18.8% | 4,265 | +25.8% | 0.20% | +9.7% |
Q3 2021 | $548,000 | -1.3% | 3,389 | 0.0% | 0.19% | -1.1% |
Q2 2021 | $555,000 | +21.2% | 3,389 | +11.4% | 0.19% | +13.3% |
Q1 2021 | $458,000 | +19.0% | 3,042 | +19.7% | 0.17% | +9.2% |
Q4 2020 | $385,000 | +48.1% | 2,542 | +32.6% | 0.15% | +28.8% |
Q3 2020 | $260,000 | -8.1% | 1,917 | -7.3% | 0.12% | -12.6% |
Q2 2020 | $283,000 | +31.6% | 2,067 | +3.8% | 0.14% | +8.9% |
Q1 2020 | $215,000 | +7.5% | 1,992 | +20.1% | 0.12% | +42.5% |
Q4 2019 | $200,000 | +566.7% | 1,659 | +848.0% | 0.09% | +295.5% |
Q2 2013 | $30,000 | – | 175 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |